Literature DB >> 24055064

Pharmacokinetics.

Jianghong Fan1, Inés A M de Lannoy2.   

Abstract

Pharmacokinetics (PK) is the study of the time course of the absorption, distribution, metabolism and excretion (ADME) of a drug, compound or new chemical entity (NCE) after its administration to the body. Following a brief introduction as to why knowledge of the PK properties of an NCE is critical to its selection as a lead candidate in a drug discovery program and/or its use as a functional research tool, the present article presents an overview of PK principles, including practical guidelines for conducting PK studies as well as the equations required for characterizing and understanding the PK of an NCE and its metabolite(s). A review of the determination of in vivo PK parameters by non-compartmental and compartmental methods is followed by a brief overview of allometric scaling. Compound absorption and permeability are discussed in the context of intestinal absorption and brain penetration. The volume of distribution and plasma protein and tissue binding are covered as is the clearance (systemic, hepatic, renal, biliary) of both small and large molecules. A section on metabolite kinetics describes how to estimate the PK parameters of a metabolite following administration of an NCE. Lastly, mathematical models used to describe pharmacodynamics (PD), the relationship between the NCE/compound concentration at the site of action and the resulting effect, are reviewed and linked to PK models in a section on PK/PD.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Absorption; Clearance; Distribution; Metabolite kinetics; Pharmacodynamics; Pharmacokinetics

Mesh:

Substances:

Year:  2013        PMID: 24055064     DOI: 10.1016/j.bcp.2013.09.007

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  41 in total

Review 1.  Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.

Authors:  Andrew B Hill; Mingfu Chen; Chih-Kuang Chen; Blaine A Pfeifer; Charles H Jones
Journal:  Trends Biotechnol       Date:  2015-12-23       Impact factor: 19.536

Review 2.  Addressing Concerns about Changing the Route of Antimicrobial Administration from Intravenous to Oral in Adult Inpatients.

Authors:  Lizanne Béïque; Rosemary Zvonar
Journal:  Can J Hosp Pharm       Date:  2015 Jul-Aug

3.  Prediction of Tissue-to-Plasma Ratios of Basic Compounds in Mice.

Authors:  Prashant B Nigade; Jayasagar Gundu; K Sreedhara Pai; Kumar V S Nemmani
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

Review 4.  Drug disposition alterations in liver disease: extrahepatic effects in cholestasis and nonalcoholic steatohepatitis.

Authors:  Mark J Canet; Nathan J Cherrington
Journal:  Expert Opin Drug Metab Toxicol       Date:  2014-07-03       Impact factor: 4.481

Review 5.  Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.

Authors:  Guido Bocci; Robert S Kerbel
Journal:  Nat Rev Clin Oncol       Date:  2016-05-17       Impact factor: 66.675

Review 6.  A Synopsis of Clinical Pharmacokinetic Alterations in Advanced CKD.

Authors:  Thomas D Nolin
Journal:  Semin Dial       Date:  2015-04-08       Impact factor: 3.455

Review 7.  100 years of modelling ligand-receptor binding and response: A focus on GPCRs.

Authors:  David B Finlay; Stephen B Duffull; Michelle Glass
Journal:  Br J Pharmacol       Date:  2020-02-28       Impact factor: 8.739

Review 8.  Pharmacology for the Audiologist.

Authors:  Tracy Offerdahl; Vallabhi Mishra
Journal:  Semin Hear       Date:  2019-04-26

9.  Pharmacokinetics, metabolism, bioavailability, tissue distribution and excretion studies of 16α-hydroxycleroda-3, 13(14) Z -dien-15, 16-olide-a novel HMG-CoA reductase inhibitor.

Authors:  Tulsankar Sachin Laxman; Santosh Kumar Puttrevu; Rajesh Pradhan; Anjali Mishra; Sarvesh Verma; Yashpal S Chhonker; Swarnim Srivastava; Suriya P Singh; Koneni V Sashidhara; Rabi Sankar Bhatta
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-06       Impact factor: 3.000

Review 10.  A human-on-a-chip approach to tackling rare diseases.

Authors:  Camilly P Pires de Mello; John Rumsey; Victoria Slaughter; James J Hickman
Journal:  Drug Discov Today       Date:  2019-08-11       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.